Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01579539Phase 3Completed
A Phase 3 trial of methylprednisolone injection in thyroid associated ophthalmopathy (TAO), sponsored by Medical University of Vienna. Started Jun 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01579539.